Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease
Authors
Keywords
-
Journal
Biomed Research International
Volume 2016, Issue -, Pages 1-15
Publisher
Hindawi Limited
Online
2016-06-29
DOI
10.1155/2016/3245935
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study
- (2018) Teodoro del Ser et al. JOURNAL OF ALZHEIMERS DISEASE
- 2015 Alzheimer's disease facts and figures
- (2015) Alzheimers & Dementia
- Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models
- (2015) Valeria Melis et al. BEHAVIOURAL PHARMACOLOGY
- Pathological Interface Between Oligomeric Alpha-Synuclein and Tau in Synucleinopathies
- (2015) Urmi Sengupta et al. BIOLOGICAL PSYCHIATRY
- Early investigational drugs targeting tau protein for the treatment of Alzheimer’s disease
- (2015) Keshav Anand et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Further understanding of tau phosphorylation: implications for therapy
- (2015) Miguel Medina et al. Expert Review of Neurotherapeutics
- Protein Folding and Mechanisms of Proteostasis
- (2015) José Díaz-Villanueva et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease
- (2015) Charles R. Harrington et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer’s Disease Mouse Model
- (2015) Aya Zakaria et al. MOLECULAR NEUROBIOLOGY
- Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits
- (2015) Sang-Won Min et al. NATURE MEDICINE
- Human secreted tau increases amyloid-beta production
- (2015) Jessica Bright et al. NEUROBIOLOGY OF AGING
- Tau immunotherapy for Alzheimer's disease
- (2015) Jan Torleif Pedersen et al. TRENDS IN MOLECULAR MEDICINE
- Nontoxic singlet oxygen generator as a therapeutic candidate for treating tauopathies
- (2015) Sahabudeen Sheik Mohideen et al. Scientific Reports
- Further understanding of tau phosphorylation: implications for therapy
- (2015) Miguel Medina et al. Expert Review of Neurotherapeutics
- The relationship between truncation and phosphorylation at the C-terminus of tau protein in the paired helical filaments of Alzheimer's disease
- (2015) Paola Flores-RodrÃguez et al. Frontiers in Neuroscience
- Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau
- (2015) Katja Hochgräfe et al. Acta Neuropathologica Communications
- Methylene Blue Protects Astrocytes against Glucose Oxygen Deprivation by Improving Cellular Respiration
- (2015) Gourav Roy Choudhury et al. PLoS One
- Alzheimer disease therapeutics: Focus on the disease and not just plaques and tangles
- (2014) Khalid Iqbal et al. BIOCHEMICAL PHARMACOLOGY
- Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer‘s disease
- (2014) Ludovic Collin et al. BRAIN
- Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer’s disease and frontotemporal lobar degeneration
- (2014) V. Melis et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Structure and Mechanism of Action of Tau Aggregation Inhibitors
- (2014) Katryna Cisek et al. Current Alzheimer Research
- Amyloid-directed monoclonal antibodies for the treatment of Alzheimer’s disease: the point of no return?
- (2014) Francesco Panza et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease
- (2014) Khalid Iqbal et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward
- (2014) Francesco Panza et al. Expert Review of Clinical Immunology
- Advances in the therapy of Alzheimer’s disease: targeting amyloid beta and tau and perspectives for the future
- (2014) Harald Hampel et al. Expert Review of Neurotherapeutics
- The green tea polyphenol (−)-epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios
- (2014) Heike J. Wobst et al. FEBS LETTERS
- Tau-Based Therapeutic Approaches for Alzheimer's Disease - A Mini-Review
- (2014) Allal Boutajangout et al. GERONTOLOGY
- Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity
- (2014) Cliona Stack et al. HUMAN MOLECULAR GENETICS
- Methylene Blue Modulates β-Secretase, Reverses Cerebral Amyloidosis, and Improves Cognition in Transgenic Mice
- (2014) Takashi Mori et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014
- (2014) L. S. Schneider et al. JOURNAL OF INTERNAL MEDICINE
- Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
- (2014) Adam L Boxer et al. LANCET NEUROLOGY
- The Glutathione System: A New Drug Target in Neuroimmune Disorders
- (2014) Gerwyn Morris et al. MOLECULAR NEUROBIOLOGY
- A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
- (2014) Eduardo Tolosa et al. MOVEMENT DISORDERS
- Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy
- (2014) Tara L. Spires-Jones et al. NEUROSCIENCE LETTERS
- First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
- (2014) Eva Kontsekova et al. Alzheimers Research & Therapy
- Mechanistic Basis of Phenothiazine-Driven Inhibition of Tau Aggregation
- (2013) Elias Akoury et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Tau-aggregation inhibitor therapy for Alzheimer's disease
- (2013) Claude M. Wischik et al. BIOCHEMICAL PHARMACOLOGY
- “Prion-Like” Templated Misfolding in Tauopathies
- (2013) Florence Clavaguera et al. BRAIN PATHOLOGY
- Dimethyl fumarate: a Janus-faced substance?
- (2013) Frieder Kees EXPERT OPINION ON PHARMACOTHERAPY
- Structural Determinants of Tau Aggregation Inhibitor Potency
- (2013) Kelsey N. Schafer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation
- (2013) Alex Crowe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antibody Uptake into Neurons Occurs Primarily via Clathrin-dependent Fcγ Receptor Endocytosis and Is a Prerequisite for Acute Tau Protein Clearance
- (2013) Erin E. Congdon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Two Novel Tau Antibodies Targeting the 396/404 Region Are Primarily Taken Up by Neurons and Reduce Tau Protein Pathology
- (2013) Jiaping Gu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Progress and Developments in Tau Aggregation Inhibitors for Alzheimer Disease
- (2013) Bruno Bulic et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of Tau Filament Formation by Conformational Modulation
- (2013) Elias Akoury et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: Protection against impairments in axonal transport
- (2013) Yan Jouroukhin et al. NEUROBIOLOGY OF DISEASE
- Therapeutic and preventive effects of methylene blue on Alzheimer's disease pathology in a transgenic mouse model
- (2013) V. Paban et al. NEUROPHARMACOLOGY
- Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy
- (2013) Clara Theunis et al. PLoS One
- Methylene blue induces macroautophagy through 5′ adenosine monophosphate-activated protein kinase pathway to protect neurons from serum deprivation
- (2013) Luokun Xie et al. Frontiers in Cellular Neuroscience
- Tau protein kinases: Involvement in Alzheimer's disease
- (2012) Ludovic Martin et al. AGEING RESEARCH REVIEWS
- Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo
- (2012) Erin E. Congdon et al. Autophagy
- Binding of methylene blue to a surface cleft inhibits the oligomerization and fibrillization of prion protein
- (2012) Paola Cavaliere et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Methylene Blue Inhibits the Function of α7-Nicotinic Acetylcholine Receptors
- (2012) Abdulla S. Al Mansouri et al. CNS & Neurological Disorders-Drug Targets
- Immunotherapy for Alzheimer’s disease: from anti-β-amyloid to tau-based immunization strategies
- (2012) Francesco Panza et al. Immunotherapy
- Curcumin Prevents Aggregation in α-Synuclein by Increasing Reconfiguration Rate
- (2012) Basir Ahmad et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Modulation of Tau Protein Fibrillization by Oleocanthal
- (2012) Maria Chiara Monti et al. JOURNAL OF NATURAL PRODUCTS
- The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice
- (2012) B. Zhang et al. JOURNAL OF NEUROSCIENCE
- The crystalline state of methylene blue: a zoo of hydrates
- (2012) Timo Rager et al. PHYSICAL CHEMISTRY CHEMICAL PHYSICS
- Neuroprotective Actions of Methylene Blue and Its Derivatives
- (2012) Ethan Poteet et al. PLoS One
- Methylene Blue Reduced Abnormal Tau Accumulation in P301L Tau Transgenic Mice
- (2012) Masato Hosokawa et al. PLoS One
- “Clicked” Sugar–Curcumin Conjugate: Modulator of Amyloid-β and Tau Peptide Aggregation at Ultralow Concentrations
- (2011) Sukanta Dolai et al. ACS Chemical Neuroscience
- Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer’s disease
- (2011) Michael Voronkov et al. Future Medicinal Chemistry
- Anti-tau oligomers passive vaccination for the treatment of Alzheimer disease
- (2011) Rakez Kayed Human vaccines & immunotherapeutics
- Alternative Mitochondrial Electron Transfer as a Novel Strategy for Neuroprotection
- (2011) Yi Wen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics
- (2011) Susanne M. Pritchard et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Novel Types of Frontotemporal Lobar Degeneration: Beyond Tau and TDP-43
- (2011) Ian R. A. Mackenzie et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
- (2011) Allal Boutajangout et al. JOURNAL OF NEUROCHEMISTRY
- Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
- (2011) Heiko Braak et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- “Lest we forget you — methylene blue …”
- (2011) R. Heiner Schirmer et al. NEUROBIOLOGY OF AGING
- The acetylation of tau inhibits its function and promotes pathological tau aggregation
- (2011) Todd J. Cohen et al. Nature Communications
- Towards a Pharmacophore for Amyloid
- (2011) Meytal Landau et al. PLOS BIOLOGY
- Role of monoamine oxidase, nitric oxide synthase and regional brain monoamines in the antidepressant-like effects of methylene blue and selected structural analogues
- (2010) Brian H. Harvey et al. BIOCHEMICAL PHARMACOLOGY
- Methylene Blue Reduces Aβ Levels and Rescues Early Cognitive Deficit by Increasing Proteasome Activity
- (2010) David X. Medina et al. BRAIN PATHOLOGY
- TAU Aggregation is a Therapeutic Target for Alzheimers Disease
- (2010) A. Takashima Current Alzheimer Research
- Towards Disease-Modifying Treatment of Alzheimers Disease: Drugs Targeting β -Amyloid
- (2010) V. Frisardi et al. Current Alzheimer Research
- Tau in Alzheimer Disease and Related Tauopathies
- (2010) K. Iqbal et al. Current Alzheimer Research
- Aggregation of Detergent-insoluble Tau Is Involved in Neuronal Loss but Not in Synaptic Loss
- (2010) Tetsuya Kimura et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epothilone D Improves Microtubule Density, Axonal Integrity, and Cognition in a Transgenic Mouse Model of Tauopathy
- (2010) K. R. Brunden et al. JOURNAL OF NEUROSCIENCE
- Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
- (2010) A. Boutajangout et al. JOURNAL OF NEUROSCIENCE
- Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden
- (2010) John C O'Leary et al. Molecular Neurodegeneration
- Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish
- (2010) Frauke van Bebber et al. NEUROBIOLOGY OF DISEASE
- Tau Phosphorylation and Cleavage in Ethanol-Induced Neurodegeneration in the Developing Mouse Brain
- (2010) Mariko Saito et al. NEUROCHEMICAL RESEARCH
- Beneficial network effects of methylene blue in an amnestic model
- (2010) Penny D. Riha et al. NEUROIMAGE
- Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
- (2010) Sang-Won Min et al. NEURON
- Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy
- (2010) Tetsuaki Arai et al. NEUROPATHOLOGY
- Tau protein and tau aggregation inhibitors
- (2010) Bruno Bulic et al. NEUROPHARMACOLOGY
- Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models
- (2009) Qipeng Zhang et al. ACTA NEUROPATHOLOGICA
- Adverse Effects of Methylene Blue on the Central Nervous System
- (2009) Laszlo Vutskits et al. ANESTHESIOLOGY
- Identification of Aminothienopyridazine Inhibitors of Tau Assembly by Quantitative High-Throughput Screening
- (2009) Alex Crowe et al. BIOCHEMISTRY
- Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models
- (2009) Makiko Yamashita et al. FEBS LETTERS
- Propagation of Tau Misfolding from the Outside to the Inside of a Cell
- (2009) Bess Frost et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure−Activity Relationship of Cyanine Tau Aggregation Inhibitors
- (2009) Edward Chang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau
- (2009) Wenkai Li et al. JOURNAL OF NEUROCHEMISTRY
- Chemical Manipulation of Hsp70 ATPase Activity Regulates Tau Stability
- (2009) U. K. Jinwal et al. JOURNAL OF NEUROSCIENCE
- Transmission and spreading of tauopathy in transgenic mouse brain
- (2009) Florence Clavaguera et al. NATURE CELL BIOLOGY
- Strong Gametocytocidal Effect of Methylene Blue-Based Combination Therapy against Falciparum Malaria: A Randomised Controlled Trial
- (2009) Boubacar Coulibaly et al. PLoS One
- Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
- (2008) C.-X. Gong et al. CURRENT MEDICINAL CHEMISTRY
- Interplay between Cyclin-Dependent Kinase 5 and Glycogen Synthase Kinase 3 Mediated by Neuregulin Signaling Leads to Differential Effects on Tau Phosphorylation and Amyloid Precursor Protein Processing
- (2008) Y. Wen et al. JOURNAL OF NEUROSCIENCE
- A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer's Disease
- (2008) Y. Matsuoka et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine
- (2008) Serena Deiana et al. PSYCHOPHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started